Mary E. Soyster
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mary E. Soyster has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Jason L. Zappia
Department of Urology, Indiana University School of Medicine, Indianapolis, IN, USA
2 shared publicationsJoshua D. Roth
Department of Urology, Indiana University School of Medicine, Indianapolis, IN, USA
2 shared publicationsM. Francesca Monn
Department of Urology, Indiana University School of Medicine, Indianapolis, IN, USA; Division of Urology, Southern Illinois University School of Medicine, Springfield, IL, USA
2 shared publicationsMatthew J. Mellon
Department of Urology, Indiana University School of Medicine, Indianapolis, IN, USA
2 shared publicationsPeter J. Arnold
Department of Urology, Indiana University School of Medicine, Indianapolis, IN, USA
2 shared publicationsRamzy T. Burns
Department of Urology, Indiana University School of Medicine, Indianapolis, IN, USA
2 shared publications
Latest Publications
- 22 November 2022
- Published by Wiley in The Prostate
- Vol. 83 (4) , 316-322
Impact of American Society of Anesthesiologists score on postoperative holmium enucleation of the prostate outcomes and complications
Introductions: The American Society of Anesthesiologists Physical Status Classification System (ASA) is a validated risk stratification method for patients undergoing surgery. There is an increased prevalence of benign prostatic hyperplasia and comorbidities in our aging population. The role of ASA related to postoperative complications in patients undergoing holmium laser enucleation of the prostate (HoLEP) has not been described.Methods: A review of our database was performed for patients who underwent HoLEP from July 2018 to December 2020. Patients were stratified based on ASA score. Preoperative, perioperative, and complication data were analyzed using SAS analytics software.Results: Of 472 patients undergoing HoLEP, 320 (67.8%) were ASA 3–4 patients. There was a statistically significant difference found in age (72.3 ± 9.8 vs. 69.1 ± 9.0 years, p < 0.001), body mass index (BMI) (29.0 ± 5.9 vs. 27.3 ± 4.2, p = 0.004), and use of antiplatelet/anticoagulant medications (14.6% vs. 2.6%, p < 0.001) in the ASA 3–4 group. There was no significant difference between prostate volume (p = 0.158) or catheter‐dependent urinary retention (p = 0.376). No difference was found in enucleation time (52.76 ± 24.8 vs. 54.16 ± 23.7 min, p = 0.587), OR specimen weight (70.24 ± 58.5 vs. 81.53 ± 65.9, p = 0.094). or intraoperative complications (2.8% vs. 1.3%, p = 0.330). There were higher postoperative complications in the ASA 3–4 group (12.8% vs. 7.9%, p = 0.03), but no difference in Clavien ≥3 complications (p = 0.068). ASA 3–4 patients had similar postoperative international prostate symptom score (p = 0.159).Conclusion: HoLEP is feasible and effective in patients who are ASA 3–4. The high‐risk cohort had an increased rate of low‐grade complications. Patients with an ASA score of 3–4 should be counseled regarding a higher rate of low‐grade complications.
- 22 November 2022
- Published by Wiley in The Prostate
- Vol. 83 (4) , 316-322
Impact of American Society of Anesthesiologists score on postoperative holmium enucleation of the prostate outcomes and complications
Introductions: The American Society of Anesthesiologists Physical Status Classification System (ASA) is a validated risk stratification method for patients undergoing surgery. There is an increased prevalence of benign prostatic hyperplasia and comorbidities in our aging population. The role of ASA related to postoperative complications in patients undergoing holmium laser enucleation of the prostate (HoLEP) has not been described.Methods: A review of our database was performed for patients who underwent HoLEP from July 2018 to December 2020. Patients were stratified based on ASA score. Preoperative, perioperative, and complication data were analyzed using SAS analytics software.Results: Of 472 patients undergoing HoLEP, 320 (67.8%) were ASA 3–4 patients. There was a statistically significant difference found in age (72.3 ± 9.8 vs. 69.1 ± 9.0 years, p < 0.001), body mass index (BMI) (29.0 ± 5.9 vs. 27.3 ± 4.2, p = 0.004), and use of antiplatelet/anticoagulant medications (14.6% vs. 2.6%, p < 0.001) in the ASA 3–4 group. There was no significant difference between prostate volume (p = 0.158) or catheter‐dependent urinary retention (p = 0.376). No difference was found in enucleation time (52.76 ± 24.8 vs. 54.16 ± 23.7 min, p = 0.587), OR specimen weight (70.24 ± 58.5 vs. 81.53 ± 65.9, p = 0.094). or intraoperative complications (2.8% vs. 1.3%, p = 0.330). There were higher postoperative complications in the ASA 3–4 group (12.8% vs. 7.9%, p = 0.03), but no difference in Clavien ≥3 complications (p = 0.068). ASA 3–4 patients had similar postoperative international prostate symptom score (p = 0.159).Conclusion: HoLEP is feasible and effective in patients who are ASA 3–4. The high‐risk cohort had an increased rate of low‐grade complications. Patients with an ASA score of 3–4 should be counseled regarding a higher rate of low‐grade complications.
- 1 June 2021
- Published by SAGE Publications in Journal of Endourology
- Vol. 35 (6) , 801-807
Robotic Sacral Colpopexy Using Autologous Fascia Lata Compared with Mesh
Objective The objective is to compare robotic sacral colpopexy (RSC) utilizing autologous fascia lata to RSC with synthetic mesh in the treatment of pelvic organ prolapse. Methods We performed a prospective non-randomized case comparison trial at a single institution. We compared RSC utilizing either synthetic mesh or autologous fascia lata in women with symptomatic pelvic organ prolapse, stages II through IV. The primary outcome was anatomic prolapse recurrence determined by the Pelvic Organ Prolapse Quantification (POP-Q) exam. Secondary outcomes included patient reported outcomes such as the Urogenital Distress Inventory-6 (UDI-6) and Incontinence Impact Questionnaire-7 (IIQ-7). Complications were also recorded and categorized using the Clavien-Dindo system (CD). The hypothesis is that autologous fascia lata would provide equivalent anatomic and patient reported outcomes compared to mesh while eliminating mesh related complications. Results Sixty-four women underwent RSC with 19 (29.7%) receiving fascia lata graft. The overall operative time was greater in the fascia lata group with mean fascia lata harvest time of 24.8±7.4 minutes. Intragroup comparisons of the fascia and mesh groups demonstrated significant improvement in pelvic measurements as well as patient reported outcomes. Intergroup comparison demonstrated equivalent success rates at 12.1±8.7 months follow up. There was one apical failure in the fascia lata RSC group, however the difference was not statistically significant (p=0.30). Significant complications in the fascia lata harvest group included two CD-II and one CD-IIIb. In the mesh group there was one mesh erosion requiring surgical excision (CD-IIIb). Conclusion This is the first comparison between RSC with autologous fascia lata vs. mesh. Short-term anatomic outcomes were similar with autologous fascia lata use without the risk of mesh erosion. Morbidity from graft harvest site was not trivial. These results emphasize the need for a randomized controlled trial.
- 1 June 2021
- Published by SAGE Publications in Journal of Endourology
- Vol. 35 (6) , 801-807
Robotic Sacral Colpopexy Using Autologous Fascia Lata Compared with Mesh
Objective The objective is to compare robotic sacral colpopexy (RSC) utilizing autologous fascia lata to RSC with synthetic mesh in the treatment of pelvic organ prolapse. Methods We performed a prospective non-randomized case comparison trial at a single institution. We compared RSC utilizing either synthetic mesh or autologous fascia lata in women with symptomatic pelvic organ prolapse, stages II through IV. The primary outcome was anatomic prolapse recurrence determined by the Pelvic Organ Prolapse Quantification (POP-Q) exam. Secondary outcomes included patient reported outcomes such as the Urogenital Distress Inventory-6 (UDI-6) and Incontinence Impact Questionnaire-7 (IIQ-7). Complications were also recorded and categorized using the Clavien-Dindo system (CD). The hypothesis is that autologous fascia lata would provide equivalent anatomic and patient reported outcomes compared to mesh while eliminating mesh related complications. Results Sixty-four women underwent RSC with 19 (29.7%) receiving fascia lata graft. The overall operative time was greater in the fascia lata group with mean fascia lata harvest time of 24.8±7.4 minutes. Intragroup comparisons of the fascia and mesh groups demonstrated significant improvement in pelvic measurements as well as patient reported outcomes. Intergroup comparison demonstrated equivalent success rates at 12.1±8.7 months follow up. There was one apical failure in the fascia lata RSC group, however the difference was not statistically significant (p=0.30). Significant complications in the fascia lata harvest group included two CD-II and one CD-IIIb. In the mesh group there was one mesh erosion requiring surgical excision (CD-IIIb). Conclusion This is the first comparison between RSC with autologous fascia lata vs. mesh. Short-term anatomic outcomes were similar with autologous fascia lata use without the risk of mesh erosion. Morbidity from graft harvest site was not trivial. These results emphasize the need for a randomized controlled trial.